A new ISO standard that helps assess the sustainability of products and processes related to bioenergy has a huge potential to tackle climate change, promote energy security and foster sustainable development.
Minneapolis Heart Institute Foundation. Summary: Most patients with ischemic cardiomyopathy and dilated cardiomyopathy who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease can live for decades, according to new research. Share:
The average duration of heart failure symptoms was 2.5 years before enrollment into the trial. The 2-year mortality in the control group was â14%, and mortality in patients randomized to ICD therapy was 23% lower than that of patients randomized to placebo over an average follow-up of almost 4 years (P=0.007).